Present Directly to Investors at RESI
RESI’s Innovator’s Pitch Challenge (IPC) is different from company presentations at other conferences. Companies pitch to a dedicated team of coordinated investors. The investors are actively engaged, not only listening but also providing interactive questions and feedback.
About RESI
The Redefining Every Stage Investments (RESI) conference series connects start-ups and investors and strategic channel partners. RESI maximizes fundraising companies’ efforts to find partners who are a fit for their technology and stage of development. RESI is uniquely cross-border and cross-domain, connecting start-ups with 10 categories of global investors across the silos of drugs, devices, diagnostics and digital health (4 Ds). RESI caters to both the earliest stage start-ups, those seeking grants, seed and angel capital, and the early-stage firms who seek series A and B funding. RESI is a unique and powerful tool for sourcing assets and advancing innovation across early-stage life science and healthcare.
Who Should Attend
RESI is committed to facilitating conversations that spark deals in across drugs, devices, diagnostics, and digital health that save lives and change the world through healthcare innovation. To advance the most successful deals, all major players, including both buyers and sellers, are saved a seat at the table. RESI attracts incubators, tech transfer offices, universities, hospitals, research labs and their constituents getting on the radar of investors and channel partners. Biotech, medtech, diagnostics, and digital health companies source global investors and strategic partners, create relationships, and pitch to secure funding from Seed to Exit.
In RESI 2024 Series
Investors get a front-row seat to emerging early-stage companies, with direct insight into product pipelines, licensing opportunities, financing rounds, technologies, and management details in order to find the best fit for their theme.
*The LSN Investor Database covers over 10,000+ active life science investors across the following 10 categories:
- Angel Groups
- Corporate Venture Capital
- Endowments/Foundations
- Family Office/Private Wealth Funds
- Government Organizations
- Hedge Funds
- Institutional Alternative Investors
- Large Pharma/ Biotech Companies
- Private Equity
- Venture Capital
CEOs gain access to investors and strategic partners actively seeking opportunities that match their product set and stage of development through a match-based partnering system, pitch opportunities, and industry expert panels.
Life Science Nation (LSN) has built a global partnering ecosystem featuring healthcare startups and the capital investors, co-development, and licensing partners who seek them. This partnering ecosystem consists of the LSN Global Partnering Campaign Database, Focus on Cures Accelerator, and the world-renowned Redefining Early-Stage Investments (RESI) conference series, which work closely with LSN’s global tech hub network.
